Trinity Biotech Plc (TRIB)
5.46
-0.86
(-13.61%)
USD |
NASDAQ |
Oct 02, 16:00
5.46
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Debt to Equity Ratio : -1.917 for Dec. 31, 2025
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2025 | -1.917 |
| September 30, 2025 | -2.142 |
| June 30, 2025 | -2.272 |
| March 31, 2025 | -2.475 |
| December 31, 2024 | -2.864 |
| September 30, 2024 | -3.558 |
| June 30, 2024 | -3.175 |
| March 31, 2024 | -3.747 |
| December 31, 2023 | -2.815 |
| September 30, 2023 | -3.832 |
| June 30, 2023 | -5.916 |
| March 31, 2023 | -11.62 |
| December 31, 2022 | -33.18 |
| September 30, 2022 | 8.731 |
| June 30, 2022 | 3.639 |
| March 31, 2022 | -12.16 |
| December 31, 2021 | -310.84 |
| September 30, 2021 | 102.67 |
| June 30, 2021 | -167.72 |
| March 31, 2021 | -661.77 |
| December 31, 2020 | -45.71 |
| September 30, 2020 | 11.75 |
| June 30, 2020 | -116.44 |
| March 31, 2020 | 107.01 |
| December 31, 2019 | 21.68 |
| Date | Value |
|---|---|
| September 30, 2019 | 2.103 |
| June 30, 2019 | 2.093 |
| March 31, 2019 | 2.285 |
| December 31, 2018 | 1.869 |
| September 30, 2018 | 1.212 |
| June 30, 2018 | 1.432 |
| March 31, 2018 | 1.447 |
| December 31, 2017 | 1.439 |
| September 30, 2017 | 0.8959 |
| June 30, 2017 | 0.8913 |
| March 31, 2017 | 0.8736 |
| December 31, 2016 | 0.8875 |
| September 30, 2016 | 0.4817 |
| June 30, 2016 | 0.471 |
| March 31, 2016 | 0.471 |
| December 31, 2015 | 0.434 |
| September 30, 2015 | 0.4695 |
| June 30, 2015 | 0.5322 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| DBV Technologies SA | 0.0784 |
| Cellectis SA | 2.539 |
| Akari Therapeutics Plc | 0.0373 |
| Autolus Therapeutics Plc | 4.915 |
| Evaxion AS | 0.7455 |
Debt to Equity Ratio Related Metrics
| Current Ratio | 0.2542 |
| Net Debt Paydown Yield | 192.2% |